BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 11159807)

  • 1. Metabolism and disposition of alpha-methylstyrene in rats.
    De Costa KS; Black SR; Thomas BF; Burgess JP; Mathews JM
    Drug Metab Dispos; 2001 Feb; 29(2):166-71. PubMed ID: 11159807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolism and disposition of 1-bromopropane in rats and mice following inhalation or intravenous administration.
    Garner CE; Sumner SC; Davis JG; Burgess JP; Yueh Y; Demeter J; Zhan Q; Valentine J; Jeffcoat AR; Burka LT; Mathews JM
    Toxicol Appl Pharmacol; 2006 Aug; 215(1):23-36. PubMed ID: 16513153
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolism and disposition of moxonidine in Fischer 344 rats.
    He MM; Abraham TL; Lindsay TJ; Chay SH; Czeskis BA; Shipley LA
    Drug Metab Dispos; 2000 Apr; 28(4):446-59. PubMed ID: 10725314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The metabolic disposition of aprepitant, a substance P receptor antagonist, in rats and dogs.
    Huskey SE; Dean BJ; Doss GA; Wang Z; Hop CE; Anari R; Finke PE; Robichaud AJ; Zhang M; Wang B; Strauss JR; Cunningham PK; Feeney WP; Franklin RB; Baillie TA; Chiu SH
    Drug Metab Dispos; 2004 Feb; 32(2):246-58. PubMed ID: 14744948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HPLC-NMR with severe column overloading: fast-track metabolite identification in urine and bile samples from rat and dog treated with [14C]-ZD6126.
    Lenz EM; D'Souza RA; Jordan AC; King CD; Smith SM; Phillips PJ; McCormick AD; Roberts DW
    J Pharm Biomed Anal; 2007 Feb; 43(3):1065-77. PubMed ID: 17030109
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NTP Technical Report on the metabolism, toxicity and predicted carcinogenicity of diazoaminobenzene (CAS No. 136-35-6).
    Ress NB;
    Toxic Rep Ser; 2002 Sep; (73):1-23, A1-C6. PubMed ID: 12370695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolism and disposition of 4-t-butylcatechol in rats and mice.
    Black SR; Mathews JM
    Drug Metab Dispos; 2000 Jan; 28(1):1-4. PubMed ID: 10611132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NTP technical report on the toxicity and metabolism studies of chloral hydrate (CAS No. 302-17-0). Administered by gavage to F344/N rats and B6C3F1 mice.
    Beland FA
    Toxic Rep Ser; 1999 Aug; (59):1-66, A1-E7. PubMed ID: 11803702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disposition and metabolism of [2-14C]epichlorohydrin after oral administration to rats.
    Gingell R; Mitschke HR; Dzidic I; Beatty PW; Sawin VL; Page AC
    Drug Metab Dispos; 1985; 13(3):333-41. PubMed ID: 2861993
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative metabolism of the renal carcinogen 1,4-dichlorobenzene in rat: identification and quantitation of novel metabolites.
    Klos C; Dekant W
    Xenobiotica; 1994 Oct; 24(10):965-76. PubMed ID: 7900412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Absorption, metabolism, and excretion of [14C]imidafenacin, a new compound for treatment of overactive bladder, after oral administration to healthy male subjects.
    Ohmori S; Miura M; Toriumi C; Satoh Y; Ooie T
    Drug Metab Dispos; 2007 Sep; 35(9):1624-33. PubMed ID: 17567733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toxicokinetics and biotransformation of 3-(4-methylbenzylidene)camphor in rats after oral administration.
    Völkel W; Colnot T; Schauer UM; Broschard TH; Dekant W
    Toxicol Appl Pharmacol; 2006 Oct; 216(2):331-8. PubMed ID: 16806338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of metabolites and disposition of tertiary amyl methyl ether in male F344 rats following inhalation exposure.
    Sumner SC; Asgharian B; Moore TA; Parkinson HD; Bobbitt CM; Fennell TR
    J Appl Toxicol; 2003; 23(6):411-7. PubMed ID: 14635265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolism and disposition of n-butyl glycidyl ether in F344 rats and B6C3F1 mice.
    Chen LJ; Lebetkin EH; Nwakpuda EI; Burka LT
    Drug Metab Dispos; 2007 Dec; 35(12):2218-24. PubMed ID: 17875671
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disposition and metabolism of radiolabeled casopitant in humans.
    Pellegatti M; Bordini E; Fizzotti P; Roberts A; Johnson BM
    Drug Metab Dispos; 2009 Aug; 37(8):1635-45. PubMed ID: 19420128
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolism, distribution and excretion of a selective N-methyl-D-aspartate receptor antagonist, traxoprodil, in rats and dogs.
    Prakash C; Cui D; Potchoiba MJ; Butler T
    Drug Metab Dispos; 2007 Aug; 35(8):1350-64. PubMed ID: 17496205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The tissue distribution, metabolism, and excretion of octachlorostyrene in the rat.
    Chu I; Villeneuve DC; Secours V; Benoit FM; Viau A
    Drug Metab Dispos; 1982; 10(6):632-5. PubMed ID: 6130912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolism and disposition of ractopamine hydrochloride by turkey poults.
    Smith DJ; Feil VJ; Huwe JK; Paulson GD
    Drug Metab Dispos; 1993; 21(4):624-33. PubMed ID: 8104121
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hexabromonaphthalene contaminants of polybrominated biphenyls: chemical composition and disposition in the rat.
    Birnbaum LS; Darcey DJ; McKinney JD
    J Toxicol Environ Health; 1983; 12(4-6):555-73. PubMed ID: 6321745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo metabolism of [14C]ruboxistaurin in dogs, mice, and rats following oral administration and the structure determination of its metabolites by liquid chromatography/mass spectrometry and NMR spectroscopy.
    Barbuch RJ; Campanale K; Hadden CE; Zmijewski M; Yi P; O'Bannon DD; Burkey JL; Kulanthaivel P
    Drug Metab Dispos; 2006 Feb; 34(2):213-24. PubMed ID: 16258078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.